Wen Y

Frontier Innovation Center, Department of Immunology, School of Basic Medical Sciences, State Key Laboratory of Systems Medicine for Cancer, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Fudan University, Shanghai 200032, China; Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China. Electronic address: wenyating@fudan.edu.cn.

14 papers · ORCID

ArticleLSD

Targeting peripheral 5-HT<sub>2A</sub>R enhances antitumor immunity in colorectal cancer.

Wen Y, Tang L, Duan W +22

Europe PMC2026
ArticleKetamine

Rapid clinical and EEG microstate changes 24 h after intranasal esketamine in major depressive disorder with suicidal ideation: a prospective paired study.

Gu T, Zhang J, Wang R +10

Europe PMC2026
ArticleKetamine

Ketamine for substance use disorders: a systematic review and meta-analysis.

Fang SP, Yang X, Zhao DC +4

Europe PMC2026
ArticlePsychedelics

Next-Generation Pharmacotherapy for Depressive Disorders: From Novel Compounds to Optimized Use of Available Drugs.

Bu F, Qin L, Lou Z +4

Europe PMC2026
ArticleKetamine

Efficacy and safety of N-methyl-d-aspartate receptor antagonists for preventing acute postoperative pain: A systematic review and network meta-analysis of randomized controlled trials.

Zhou J, Wen Y, Xu S +3

Europe PMC2026
ArticleKetamine

Esketamine Alleviates Postoperative Cognitive Dysfunction via Rock2/Add1 Signaling Pathway in Aged Mice.

Xu C, Zhang Y, Liu Y +7

Europe PMC2026
ArticleKetamine

Low-dose esketamine combined with propofol versus fentanyl-propofol for preventing hypoxemia during gastroscopy sedation in high-altitude residents: a randomized controlled trial.

Xue H, Wei P, Wen Y +3

Europe PMC2025
ArticlePsilocybin

Structural basis for psilocybin biosynthesis.

Meng C, Guo W, Xiao C +10

Europe PMC2025
ArticleKetamine

Esketamine ameliorates prenatal stress-induced postpartum depression and sex-related behavioral differences in adolescent progeny.

Wen Y, Zhou J, Yu H +7

Europe PMC2025
ArticleKetamine

Efficacy and safety of perioperative application of esketamine on postoperative depression: a meta-analysis of randomized controlled studies.

Wen Y, Mao M, Jiang M +6

Europe PMC2025
ArticleKetamine

Efficacy and safety of perioperative application of esketamine on postpartum depression: A meta-analysis of randomized controlled studies.

Wen Y, Mao M, Wang X +7

Europe PMC2024
ArticleKetamine

Esketamine Prevents Postoperative Emotional and Cognitive Dysfunction by Suppressing Microglial M1 Polarization and Regulating the BDNF-TrkB Pathway in Ageing Rats with Preoperative Sleep Disturbance.

Wen Y, Xu J, Shen J +5

Europe PMC2024
ArticleKetamine

Evaluation of clinical effects of Esketamine on depression in patients with missed miscarriage: A randomized, controlled, double-blind trial.

Jiang M, Li Q, Mao M +5

Europe PMC2023
ArticleKetamine

The effect of low-dose esketamine on pain and post-partum depression after cesarean section: A prospective, randomized, double-blind clinical trial.

Shen J, Song C, Lu X +4

Europe PMC2022